KCNH2 Variant T421fsX
Summary of observed carriers, functional annotations, and structural context for KCNH2 T421fsX. Data combine curated literature, international cohorts, and gnomAD observations.
Estimated LQT2 penetrance
%
NA/NA effective observations
Total carriers
3
3 LQT2 · 0 unaffected
Functional studies
2
Publications with functional data
In silico predictors
| PROVEAN | PolyPhen-2 | BLAST-PSSM | REVEL | Penetrance Density LQT2 (%) |
|---|---|---|---|---|
| None | None | None | None |
PROVEAN scores below -2 suggest deleterious impact. REVEL scores above 0.5–0.75 are often interpreted as likely pathogenic. PolyPhen-2 scores above 0.85 are typically pathogenic. BLAST-PSSM reflects evolutionary conservation; more negative values indicate rarer substitutions. Penetrance density summarises neighbouring residue risk (Kroncke et al. 2019).
Reported carrier data
| Source | Year | Carriers | Unaffected | LQT2 | Other Disease |
|---|---|---|---|---|---|
| 7889573 | 1995 | 4 | 0 | 3 | |
| Literature, cohort, and gnomAD | – | 3 | 0 | 3 | – |
| Variant features alone | – | 10 | NA | NA | – |
Totals may differ from individual publications due to duplicate patients removed during curation.
Functional data
Functional assay results from published electrophysiology studies. Steady state (S.S.) and peak tail current are relative % to wildtype (100% being no different from wildtype). V1/2 activation and inactivation are the voltages at which half of the maximal current is reached, in mV. Recovery from inactivation and deactivation time are ratios of characteristic time constants with wildtype. HM indicates homomeric channels, HT indicates heteromeric channels.
Homomeric channel data
| PubMed ID | Cell Type | S.S Peak (%WT) | Peak Tail IKr (%WT) | V1/2 Act. | V1/2 Inact. | Recov. Inact. | Deactivation (%WT) |
|---|---|---|---|---|---|---|---|
| 8700910 | Xeno | 0 | None | None | None | None | |
| 8995352 | COS7 | None | None | None | None |